Improvement in health utility in patients with psoriatic arthritis treated with adalimumab (HUMIRA®)

被引：0
|
作者：
Guh, D
Bansback, NJ
Nosyk, B
Melilli, LE
Anis, A
机构：
[1] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada
[2] Abbott Labs, Ctr Pharmaceut Appraisal & Outcomes Res, Chicago, IL USA
[3] Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1W5, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：401 / 401
页数：1
相关论文
共 50 条
  • [1] Improvement in health utility in patients with psoriatic arthritis treated with adalimumab (HUMIRA®)
    Anis, AH
    Guh, D
    Melilli, LE
    [J]. VALUE IN HEALTH, 2005, 8 (06) : A27 - A27
  • [2] Clinical remission in patients with psoriatic arthritis (PsA) treated with adalimumab (humira®). results of the stereo trial
    Van den Bosch, F.
    Manger, B.
    Goupille, P.
    McHugh, N.
    Kron, M.
    Kary, S.
    Kupper, H.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : 743 - 743
  • [3] Adalimumab (HUMIRA®) monotherapy provides sustained long-term improvement in health utility in patients with rheumatoid arthritis (RA)
    Dietz, BM
    Van de Putte, LBA
    Holtbrügge, W
    Kupper, H
    Raschke, U
    Unnebrink, K
    Sterz, R
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 393 - 393
  • [4] Adalimumab (HUMIRA®) monotherapy significantly improves health utility in patients with severe rheumatoid arthritis (RA)
    Dietz, BM
    Sterz, R
    Holtbrügge, W
    Kupper, H
    Van de Putte, LBA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 392 - 392
  • [5] Impact of Adalimumab (HUMIRA®) on Work Productivity in Patients with Psoriatic Arthritis: Results from ACCLAIM
    Gladman, Dafna D.
    Psaradellis, Fotoula
    Martel, Marie-Josee
    Illouz, Olivier
    Guerette, Benoit
    Sampalis, John S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S148 - S149
  • [6] Improvement in psoriasis is associated with long-term inhibition of radiographic progression in patients with psoriatic arthritis receiving adalimumab (HUMIRA®)
    Choy, Ernest
    Gladman, Dafna D.
    Mease, Philip
    Ritchlin, Christopher
    Olds, Michele
    Wong, Robert
    Wang, Shuhe
    Medich, John
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S575 - S576
  • [7] The cost-utility of adalimumab (Humira) in patients with rheumatoid arthritis (RA) in Denmark
    Aagren, M.
    Davies, A.
    Pang, F.
    Winding, B.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A223 - A223
  • [8] Improvement in health-related quality of life, health utility, and fatigue in patients with active rheumatoid arthritis (RA) on adalimumab (HUMIRA™, Abbott) therapy.
    Strand, V
    Chartash, E
    Sengupta, N
    Chang, KY
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S402 - S403
  • [9] Clinical remission and good clinical responses in patients with psoriatic arthritis (PsA) treated with adalimumab (HUMIRA®):: Results of the STEREO trial
    Van den Bosch, Filip
    Manger, Bernhard
    Goupille, Philippe
    Kron, Martina
    Kary, Sonja
    Kupper, Hartmut
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S576 - S576
  • [10] Impact of Adalimumab (HUMIRA®) on Work Productivity in Patients With Psoriatic Arthritis: Results From ACCLAIM
    Gladman, D. D.
    Psaradellis, F.
    Martel, M. J.
    Illouz, O.
    Guerette, B.
    Sampalis, J. S.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2595 - 2596
12345